Peking University Third Hospital
Clinical trials sponsored by Peking University Third Hospital, explained in plain language.
-
New bladder cancer combo shows promise in Pre-Surgery trial
Disease control Recruiting nowThis study tests whether a new combination of drugs (enfortumab vedotin plus toripalimab) works better than standard chemotherapy before bladder cancer surgery. About 58 adults with high-risk muscle-invasive bladder cancer will be randomly assigned to one of the two treatments fo…
Phase: PHASE2 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New study tests stronger ankle surgery for people with loose joints
Disease control Recruiting nowThis study compares two surgical methods to treat chronic ankle instability in people who also have joint hypermobility (very flexible joints). One method adds a special tape for extra support. The goal is to see which surgery provides better stability and fewer repeat injuries. …
Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Ancient herb mix could speed heart surgery recovery
Disease control Recruiting nowThis study looks at whether a traditional Chinese herbal prescription called Fuzheng Yangxin can help people recover more quickly after coronary artery bypass grafting. Researchers will follow 300 patients with a specific post-surgery syndrome (Qi-Yin deficiency) to see if the he…
Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Immune cells injected into brain to fight tumors
Disease control Recruiting nowThis study tests a new treatment using natural killer (NK) cells, a type of immune cell, for adults with aggressive brain tumors that have not responded to standard therapies. The NK cells are grown in a lab and then given through a vein and directly into the brain. The main goal…
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New combo therapy offers hope for Tough-to-Treat lymphoma
Disease control Recruiting nowThis study tests a combination of two drugs, glofitamab and lenalidomide, in people with a fast-growing type of lymphoma (mantle cell lymphoma) that has come back or not responded to treatment, especially after a BTK inhibitor stopped working. About 43 adults will receive the dru…
Phase: PHASE2 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New ointment could heal diabetic ulcers faster
Disease control Recruiting nowThis trial tests whether a natural ointment called Xiang Lei Ointment can help heal diabetic ulcers better than standard care alone. The ointment aims to reduce inflammation and promote wound repair. The study will enroll 56 adults with diabetes and a foot or leg ulcer that is in…
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New drug and high-tech scans aim to calm thyroid eye disease
Disease control Recruiting nowThis study tests a drug called teprotumumab N01 in 50 adults with thyroid eye disease, an autoimmune condition that causes bulging eyes and discomfort. Participants receive the drug and are monitored with special PET and MRI scans to see if inflammation and eye changes improve. T…
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a traditional chinese medicine help stop lung scarring?
Disease control Recruiting nowThis study tests whether tetrandrine tablets can improve lung function in people with interstitial lung disease caused by connective tissue disease (like lupus or scleroderma). One hundred adults will receive either tetrandrine or a placebo for 24 weeks, alongside their usual tre…
Phase: PHASE4 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New study seeks to unlock secrets of vitiligo Cream's success
Disease control Recruiting nowThis study is testing a cream called ruxolitinib on 170 people with vitiligo, a skin condition that causes white patches. The goal is to find out what factors help the cream work best. Participants must be 12 or older and have mild to moderate vitiligo. They will stop other treat…
Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New shingles drug brivudine aims to beat standard treatment in pain battle
Disease control Recruiting nowThis clinical trial compares two drugs for shingles (herpes zoster): brivudine and famciclovir. The study will enroll 140 adults with acute shingles to see which drug better reduces pain and speeds up healing. Researchers will track pain levels for up to 90 days and monitor for l…
Phase: PHASE4 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New dressing could speed healing of chronic wounds
Disease control Recruiting nowThis study tests a new antibacterial absorbable dressing on 30 adults with chronic non-healing wounds. The dressing is designed to break down in the body and help wounds heal faster. Researchers will measure how much the wound shrinks after 3 weeks and how many wounds fully close…
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New triple therapy aims to wipe out mantle cell lymphoma
Disease control Recruiting nowThis study tests a combination of three drugs—pomalidomide, orelabrutinib, and zuberitamab—in people with untreated mantle cell lymphoma, a type of blood cancer. The goal is to see if the treatment can reduce cancer cells to undetectable levels after six cycles. Participants who …
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Gentler heart bypass: new No-Touch aorta technique tested in 260-Patient trial
Disease control Recruiting nowThis study tests a new, less invasive way to perform coronary artery bypass grafting (CABG) that avoids touching the aorta. The new method uses a small incision in the left chest, while the standard approach opens the chest fully. Researchers will compare how well the bypass graf…
Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:19 UTC
-
New ultrasound technique could spot cancer in lymph nodes without a needle
Diagnosis Recruiting nowThis study tests a new type of ultrasound called super-resolution ultrasound (SRUS) to see if it can better tell the difference between benign (non-cancerous) and malignant (cancerous) swollen lymph nodes. About 779 adults with abnormal lymph nodes will receive an injection of ul…
Sponsor: Peking University Third Hospital • Aim: Diagnosis
Last updated Jun 26, 2026 13:47 UTC
-
Can preventive surgery stop ovarian cancer in High-Risk women?
Prevention Recruiting nowThis study looks at different preventive surgeries for women with gene mutations that raise their risk of ovarian cancer. Researchers want to see if removing the fallopian tubes first and delaying ovary removal works as well as standard surgery or close monitoring. About 480 wome…
Sponsor: Peking University Third Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
Pre-Surgery workouts may boost knee recovery after ACL rupture
Symptom relief Recruiting nowThis study looks at whether doing exercise rehabilitation before surgery can improve bone density, tendon healing, balance, and knee function in people with an ACL tear. Researchers will follow 60 participants aged 18 to 40 who are having their first ACL reconstruction. The goal …
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Mind over knee: pre-surgery therapy may boost ACL recovery
Symptom relief Recruiting nowThis study tests whether a short cognitive-behavioral program before anterior cruciate ligament (ACL) reconstruction can reduce fear of movement and improve physical function. 44 patients aged 18-45 will be randomly assigned to either the psychological intervention or standard ca…
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Can a wearable device replace In-Person rehab for shoulder surgery patients?
Symptom relief Recruiting nowThis study compares a wearable device-based remote rehabilitation system to traditional in-person therapy for people recovering from rotator cuff surgery. 72 adults with small to medium tears will be randomly assigned to either group. The goal is to see if the wearable approach c…
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Smart sleeve could unlock frozen shoulders without the clinic
Symptom relief Recruiting nowThis study compares traditional in-person rehab with a new intelligent wearable system for frozen shoulder patients. 42 adults aged 40-60 will use either standard therapy, the smart system, or a combination. The goal is to see if the wearable approach improves shoulder movement a…
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Can visual-guided balance training get ACL patients back on their feet faster?
Symptom relief Recruiting nowThis study looks at whether adding visual-guided balance training to standard rehab can improve knee function and walking patterns in people who had ACL reconstruction. 45 patients will be split into two groups: one doing standard rehab plus regular balance exercises, and the oth…
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Heart bypass breakthrough? new imaging may boost graft success
Knowledge-focused Recruiting nowThis study looks at whether a special imaging technique called Quantitative Flow Reserve (QFR) can help predict how well a blood vessel graft will work after coronary artery bypass surgery. Researchers will follow 110 patients for one year after surgery to check if the grafts sta…
Sponsor: Peking University Third Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New study aims to predict kidney cancer outcomes more accurately
Knowledge-focused Recruiting nowThis study uses data from 4,700 kidney cancer patients treated at a single hospital over 12 years. The goal is to create a new model that better predicts how the disease will progress, especially for patients with a tumor thrombus. Researchers will also test whether using this mo…
Sponsor: Peking University Third Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
200 RA patients join study to unlock secrets of treatment resistance
Knowledge-focused Recruiting nowThis study will follow 200 adults with rheumatoid arthritis (RA) that does not respond well to standard treatments, known as refractory RA. The goal is to learn more about why some people have hard-to-treat RA and find clues to better personalize their care. Participants will be …
Sponsor: Peking University Third Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
4,500-Patient study aims to predict heart and kidney risks
Knowledge-focused Recruiting nowThis study will follow about 4,500 people with cardiovascular-kidney-metabolic (CKM) syndrome for at least 3 years. Researchers will collect blood samples and use stress echocardiograms to look for biomarkers that predict major heart problems like heart attack or stroke. The goal…
Sponsor: Peking University Third Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
IVF timing tweaked: could waiting 1-2 days boost baby chances?
Knowledge-focused Recruiting nowThis study compares the usual timing of the 'trigger' shot in IVF with a 1-2 day delay. Researchers want to see if waiting longer leads to more high-quality embryos and higher live birth rates. About 834 women undergoing their first or second IVF cycle will take part.
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC